NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Multiple myeloma. Version 3.2023. Fort Washington: National Comprehensice Cancer Network; 2022.

Google Scholar 

Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91(1):101–19. https://doi.org/10.1016/j.mayocp.2015.11.007.

Article  PubMed  Google Scholar 

Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up(dagger). Ann Oncol. 2021;32(3):309–22. PubMed PMID: 33549387.

CAS  PubMed  Google Scholar 

Bianchi G, Anderson KC. Understanding biology to tackle the disease: multiple myeloma from bench to bedside, and back. CA Cancer J Clin. 2014;64(6):422–44.

PubMed  Google Scholar 

Lynch HT, Ferrara K, Barlogie B, Coleman EA, Lynch JF, Weisenburger D, et al. Familial myeloma. N Engl J Med. 2008;359(2):152–7. https://doi.org/10.1056/NEJMoa0708704.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, et al. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European myeloma network. Haematologica. 2014;99(6):984–96. PubMed PMID: 24658815; PubMed Central PMCID: PMCPMC4040895.

PubMed  PubMed Central  Google Scholar 

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. https://doi.org/10.1016/S0140-6736(17)33326-3. Epub 2018/02/06.

Article  PubMed  PubMed Central  Google Scholar 

Finkel KW, Cohen EP, Shirali A, Abudayyeh A. American society of nephrology Onco-Nephrology F. Paraprotein-Related kidney disease: evaluation and treatment of myeloma cast nephropathy. Clin J Am Soc Nephrol. 2016;11(12):2273–9. 01640216. PubMed PMID: 27526708; PubMed Central PMCID: PMCPMC5142056.

CAS  PubMed  PubMed Central  Google Scholar 

Kastritis E, Terpos E, Dimopoulos MA. Current treatments for renal failure due to multiple myeloma. Expert Opin Pharmacother. 2013;14(11):1477–95. https://doi.org/10.1517/14656566.2013.803068.

Article  CAS  PubMed  Google Scholar 

Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report. Blood. 2015;125(13):2068–74. https://doi.org/10.1182/blood-2014-12-615187.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith D, Yong K. Advances in understanding prognosis in myeloma. Br J Haematol. 2016;175(3):367–80. https://doi.org/10.1111/bjh.14304.

Article  PubMed  Google Scholar 

Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055–68. https://doi.org/10.1183/09031936.00059814.

Article  PubMed  PubMed Central  Google Scholar 

Fan ZY, Yang Y, Zhang CH, Yin RY, Tang L, Zhang F. Prevalence and patterns of comorbidity among Middle-Aged and elderly people in china: A Cross-Sectional study based on CHARLS data. Int J Gen Med. 2021;14:1449–55. PubMed PMID: 33907449; PubMed Central PMCID: PMCPMC8071077.

PubMed  PubMed Central  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Introduction and methodology: standards of care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S1–4. https://doi.org/10.2337/dc23-Sint. Epub 2022/12/13.

Article  PubMed  Google Scholar 

Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–51. https://doi.org/10.1016/S0140-6736(17)30058-2.

Article  CAS  PubMed  Google Scholar 

Hodgens A, Sharman T. Corticosteroids. Treasure Island (FL): StatPearls; 2023.

Google Scholar 

American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–90. https://doi.org/10.2337/dc14-S081. Epub 2013/12/21.

Article  Google Scholar 

Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014;30(2):96–102. https://doi.org/10.1002/dmrr.2486.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358–62. https://doi.org/10.4158/EP.12.4.358.

Article  PubMed  Google Scholar 

Tentolouris A, Ntanasis-Stathopoulos I, Eleftheriadou I, Malandrakis P, Tzeravini E, Gavriatopoulou M. Diabetes mellitus and multiple myeloma; common features of two distinct entities. Diabetes Metab Res Rev. 2022;38(5): e3535. https://doi.org/10.1002/dmrr.3535.

Article  PubMed  Google Scholar 

Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, et al. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer. 2014;111(3):628–36. https://doi.org/10.1038/bjc.2014.307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson PG, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, et al. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline. Br J Haematol. 2009;144(6):895–903. https://doi.org/10.1111/j.1365-2141.2008.07573.x.

Article  CAS  PubMed  Google Scholar 

Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol. 2006;24(19):3113–20. https://doi.org/10.1200/JCO.2005.04.7779.

Article  CAS  PubMed  Google Scholar 

Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010;33(4):931–9. https://doi.org/10.2337/dc09-1721. Epub 2010/03/31.

Article  PubMed  PubMed Central  Google Scholar 

Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300(23):2754–64. PubMed PMID: 19088353; PubMed Central PMCID: PMCPMC3093051.

CAS  PubMed  PubMed Central  Google Scholar 

Gong IY, Cheung MC, Read S, Na Y, Lega IC, Lipscombe LL. Association between diabetes and haematological malignancies: a population-based study. Diabetologia. 2021;64(3):540–51. https://doi.org/10.1007/s00125-020-05338-7.

Article  CAS  PubMed  Google Scholar 

Chiu BC, Gapstur SM, Greenland P, Wang R, Dyer A. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2348–54. https://doi.org/10.1158/1055-9965.EPI-06-0007.

Article  CAS  PubMed  Google Scholar 

Khan AE, Gallo V, Linseisen J, Kaaks R, Rohrmann S, Raaschou-Nielsen O, et al. Diabetes and the risk of non-Hodgkin’s lymphoma and multiple myeloma in the European prospective investigation into cancer and nutrition. Haematologica. 2008;93(6):842–50. https://doi.org/10.3324/haematol.12297.

Article  PubMed  Google Scholar 

Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R, et al. Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int. 2014. https://doi.org/10.1155/2014/461917. 2014:461917. Epub 2014/05/28.

Article  PubMed  PubMed Central  Google Scholar 

Sanchez L, Sylvester M, Parrondo R, Mariotti V, Eloy JA, Chang VT. In-hospital mortality and post-transplantation complications in elderly multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a population-based study. Biol Blood Marrow Transpl. 2017;23(7):1203–7. https://doi.org/10.1016/j.bbmt.2017.03.012.

Article  Google Scholar 

Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J, Howse P, et al. The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. BMJ Open Diabetes Res Care. 2017;5(1): e000336. https://doi.org/10.1136/bmjdrc-2016-000336.

Article